Home
 /
Papers
 /
Systems Biology
 /
Scaling perturbations: beyond genome-scale CRISPR screens
Preprint
Open access
V1
Top 1% · Validated by QED

Scaling perturbations: beyond genome-scale CRISPR screens

Anran Tang, Rico C. Ardy, Rafaela E. Mendes +1 more
January 2026
 ·
bioRxiv
 ·
DOI 
10.64898/2026.01.16.699948
94
%
Reproducible
QED Impressions
This paper passed independent validation.
QED's automated review checked the evidence supporting each claim, the statistical methods, and whether the results are reproducible from the data provided.

It ranks in the top 1% of preprints assessed in Systems Biology this quarter.
Run full QED analysis
Read paper
Save

Why this is interesting

Two synergistic innovations—RNA-based lineage screening and transformation-free library cloning—shatter the scale limits of genetic interaction mapping, delivering 665,856 pairwise perturbations in human cells and charting a credible path to comprehensive genome-scale interaction maps.

QED claims analysis

Summary

PORTAL, a reporter-based screening method that encodes perturbation effects in expressed transcripts, combined with CAP cloning for ultrahigh-complexity library construction, enables genetic interaction mapping at unprecedented scale in human cells, generating a 665,856-condition map across 46 million clonal lineages that reveals interpretable biological relationships spanning pathway-level organization, protein complex architecture, and individual gene functions using a non-fitness transcriptional phenotype.

See full analysis
Main Claim 1 –

PORTAL Encodes Perturbations in RNA for Quantitative Lineage Phenotyping

Supporting evidence

  • PORTAL Shows High Replicate Reproducibility for Reporter and Identity Signals
  • Divergent Mini Pol III Promoters Enable Robust Dual-sgRNA Expression
  • Combinatorial Indexing PORTAL Enables Single-Cell Variability Across 30-Fold Range
Main Claim 2 –

CAP Cloning Enables Ultrahigh-Complexity Lentiviral Libraries Without Bacteria

Main Claim 3 –

PORTAL plus CAP Cloning Produces Massive AP-1 Genetic Interaction Map

Supporting evidence

  • AP-1 GI Map Resolves Pathways, Subcomplex Architecture, and Gene Functions
  • √PCP Matrix Completion Recovers GI Structure from Sparse Sampling

Abstract

CRISPR screens have become essential tools for systematically probing gene function from basic biology to drug discovery, yet important frontiers remain beyond genome scale. Probing regulatory elements, interpreting genetic variants, and mapping genetic interactions all challenge the sensitivity and scalability of existing approaches. Here we introduce two synergistic technologies to address these limitations. PORTAL (Perturbation Output via Reporter Transcriptional Activity in Lineages) shifts pooled genetics toward quantitative RNA phenotypes, encoding perturbation effects in expressed transcripts to enable single-molecule measurements with lineage or single-cell resolution. CAP cloning (Covalently closed Assembly Products) bypasses bacterial transformation to enable construction of ultrahigh-complexity lentiviral libraries. Combining these advances, we construct a genetic interaction map spanning 665,856 pairwise perturbations across 46 million clonal lineages—the largest exhaustive map in human cells and the first at this scale using a non-fitness phenotype. More broadly, this work charts a path toward comprehensive genetic interaction mapping in human cells.

Related papers

How the QED Score works

QED Score is a validated AI-based quality metric that evaluates life science papers on two dimensions: originality and validity. Each manuscript is anonymized, broken down into its claims and supporting evidence, and examined by specialized AI agents for statistical rigor, consistency across figures, and fit with the existing literature. Scores are percentile ranks, so they're comparable across fields. In blinded tests, expert professors sided with QED Score over journal rank in 75% of decisive cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?